Suppr超能文献

[难治性绒毛膜癌的治疗]

[The treatment of refractory choriocarcinoma].

作者信息

Takamizawa Y, Inaba N, Matsui H

机构信息

Chiba University Faculty of Medicine, Dept. of Obstetrics & Gynecology.

出版信息

Gan To Kagaku Ryoho. 1990 Sep;17(9):1843-7.

PMID:2393304
Abstract

The choriocarcinoma was one of the most curable malignant neoplasms. This is chiefly because the effective chemotherapy was introduced and the sensitivity of hCG was improved. But about 10-20% cases with choriocarcinoma were drug resistant or recurrent cases. And now, the treatment of these refractory choriocarcinomas were one of the most important clinical problems. We describe a new combination chemotherapy for these refractory choriocarcinomas in this paper. This high dose 5-FU + Act-D protocol was effective for drug resistant cases with MEA protocol.

摘要

绒毛膜癌是最可治愈的恶性肿瘤之一。这主要是因为引入了有效的化疗方法,并且人绒毛膜促性腺激素(hCG)的敏感性得到了提高。但是,约10%-20%的绒毛膜癌病例存在耐药或复发情况。目前,这些难治性绒毛膜癌的治疗是最重要的临床问题之一。在本文中,我们描述了一种针对这些难治性绒毛膜癌的新联合化疗方案。这种高剂量5-氟尿嘧啶(5-FU)+放线菌素D(Act-D)方案对采用MEA方案的耐药病例有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验